Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease
Clinical trial NCT00105300 · COMPLETED
Trial details
- NCT number
- NCT00105300
- Sponsor
- Abbott
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-10-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.